Cosmos Health Online Sales Surge as British Demand Drives Record Profits
London, Wednesday, 4 November 2026.
Cosmos Health’s Amazon UK business reached $2.27 million in annual sales, generating a 23 percent profit margin while keeping advertising costs remarkably low at just 2.4 percent.
Record-Breaking Growth on Amazon UK
Cosmos Health Inc. (NASDAQ: COSM), a healthcare group specializing in nutraceuticals, has reported a remarkable 90% surge in its Amazon UK sales over the trailing twelve months (TTM) ending November 2, 2026, reaching $2.27 million in gross revenue [1]. This performance eclipses the prior period’s $1.19 million, underscoring a period of sustained demand that peaked between July and October 2026, when monthly sales consistently exceeded $215,000 [1]. The company sold 116,978 units during this period, averaging approximately 320 units per day [1].
Profitability and Efficiency Highlight Operational Strength
Beyond revenue growth, Cosmos Health’s Amazon UK channel demonstrated exceptional profitability, generating $525,000 in net profit—a 23% net margin after accounting for fulfillment, advertising, value-added tax, and other direct costs [1]. Advertising expenditure remained notably efficient at just 2.4% of sales, while product refund rates stayed below 1%, reflecting strong customer satisfaction and operational discipline [1]. CEO Greg Siokas emphasized the quality of this growth, stating that the channel’s performance supports the company’s transition toward a high-margin business model [1].
Strategic Expansion and Market Positioning
Cosmos Health’s Amazon UK success coincides with a broader strategic shift under CEO Greg Siokas, who noted that the platform has evolved into a ‘multi-million-dollar business’ for the company [1]. The group, which operates nutraceutical brands such as Sky Premium Life and manufactures products via its Greece-based subsidiary Cana Laboratories, has positioned the UK market as a key growth driver within its European operations [2]. As of November 1, 2026, Cosmos Health reported annual sales of $65.27 million and a market capitalization of $30.69 million, trading at $0.30 per share [2]. Despite a historically volatile stock performance with a beta of 4.73, the company’s operational metrics—including a current ratio of 1.05 and a quick ratio of 0.92—indicate a stable liquidity position [2].
Future Outlook: Ambitious Growth Projections
Looking ahead, Cosmos Health has set ambitious targets for its Amazon UK channel, forecasting a 72% increase in annual sales to approximately $3.9 million over the next twelve months [1]. This projection translates to average monthly sales of around $325,000, building on the momentum achieved in the final months of 2026 [1]. The company has not provided granular details on the specific drivers behind this growth, though management’s emphasis on ‘efficient, profitable growth’ suggests continued focus on cost control and scalable marketing strategies [1]. Investors will likely await further updates during the company’s next earnings report, scheduled for November 13, 2026 [2].